Author

M.-E. Taplin

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Organism:mouse· 1 Approach:statistical model· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

A. Boosma-Moody· 1 shared A. Juncker-Jensen· 1 shared A. K. Tewari· 1 shared A. M. Egloff· 1 shared A. R. Parikh· 1 shared A. T. M. Cheung· 1 shared B. D. Miller· 1 shared B. E. Johnson· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 14 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Boosma-Moody

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Targeting of a STING Agonist to Perivascular Macrophages in Prostate Tumors Delays Resistance to Androgen Deprivation Therapy

H. Al-janabi, K. Moyes, R. J. Allen, M. Fisher, M. Crespo, B. Gurel, P. Rescigno, J. De Bono, H. Nunns, C. Bailey, A. Juncker-Jensen, M. Muthana, W. A. Phillips, H. Pearson, M.-E. Taplin, , C. E. Lewis

This study shows targeting a STING agonist to perivascular macrophages in ADT-treated prostate tumors delays castration resistance prostate cancer onset.

bioRxiv · Apr 11, 2024Cancer Biology

Ultrasensitive detection of circulating LINE-1 ORF1p as a specific multi-cancer biomarker

M. S. Taylor, W. Connie, P. C. Fridy, S. J. Zhang, Y. Senussi, J. C. Wolters, W.-C. Cheng, J. Heaps, B. D. Miller, K. Mori, L. Cohen, H. Jiang, K. R. Molloy, B. L. Norden, B. T. Chait, , O. H. Yilmaz

This study develops ultrasensitive assays to detect ORF1p in plasma, showing its potential as a multi-cancer biomarker for early detection and monitoring.

bioRxiv · Jan 25, 2023 · PreprintCancer Biology

Molecular features of exceptional response to neoadjuvant anti-androgen therapy in high-risk localized prostate cancer

A. K. Tewari, A. T. M. Cheung, J. Crowdis, J. R. Conway, S. Y. Camp, S. A. Wankowicz, D. G. Livitz, J. Park, R. T. Lis, A. Boosma-Moody, M. X. He, S. H. AlDubayan, Z. Zhang, R. R. McKay, I. Leshchiner, , E. Van Allen

bioRxiv · Apr 20, 2021Cancer Biology